FeesSafety
Pluang+

Phaos Tech flags doubt on its ability to continue operating, citing financial challenges and plans to raise funds.

Market News
27 Oct 2026, 01:00 WIB
GlobeNewsWire
View Source
Bearish
Phaos Tech flags doubt on its ability to continue operating, citing financial challenges and plans to raise funds.

Phaos Technology Holdings disclosed that its auditor expressed substantial doubt about the company's ability to continue as a going concern due to financial difficulties. Management has no immediate plans for liquidation and aims to improve finances through debt and equity financing, product sales, and potential shareholder support. However, these plans are not guaranteed to resolve the uncertainty. The company is also pursuing a strategic shift toward engineering, procurement, and construction (EPC) to broaden its business scope, but this remains in development and depends on securing necessary resources and approvals.

Phaos Technology Holdings' recent disclosure is presented here with Technology sector market data from Pluang. For readers following Technology stocks, 89 of 150 US stocks rose while 61 fell as of Oct 27, 2026 05:11 WIB. Notable movers include CLS at USD 287.61 with a 10.61% increase and 98% buy orders, AXTI at USD 57.46 up 10.33%, and CRDO at USD 158.90 rising 7.88%.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App